Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2006-10-10
2006-10-10
Wang, Shengjun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S613000, C514S617000
Reexamination Certificate
active
07119120
ABSTRACT:
Disclosed are compounds which have been identified as inhibitors of phosphate transport. Many of the compounds are represented by Structural Formula (I):in-line-formulae description="In-line Formulae" end="lead"?Ar1—W—X—Y—Ar2;in-line-formulae description="In-line Formulae" end="tail"?or a pharmaceutically acceptable salt thereof. Ar1and Ar2are independently a substituted or unsubstituted aryl group or an optionally substituted five membered or six membered non-aromatic heterocylic group fused to an optionally substituted monocylic aryl group. W and Y are independently a covalent bond or a C1–C3 substituted or unsubstituted alkylene group. X is a heteroatom-containing functional group, an aromatic heterocyclic group, substituted aromatic heterocyclic group, non-aromatic heterocyclic group, substituted non-aromatic heterocyclic group, an olefin group or a substituted olefin group. Also disclosed are methods of treating a subject with a disease associated with hyperphosphatemia, as well as a disease mediated by phosphate-transport function. The methods comprise the step of administering an effective amount of the one of the compounds described above.
REFERENCES:
patent: 5496545 (1996-03-01), Holmes-Farley et al.
patent: 5667775 (1997-09-01), Holmes-Farley et al.
patent: 5716993 (1998-02-01), Ozaki et al.
patent: 6083495 (2000-07-01), Holmes-Farley et al.
patent: 2003/0187033 (2003-10-01), Brendel et al.
patent: 0 686 625 (1995-12-01), None
patent: 0 947 500 (1999-10-01), None
patent: WO 01 05398 (2001-01-01), None
patent: WO 01 82924 (2001-11-01), None
patent: WO 01 87294 (2001-11-01), None
Database Chemcats 'Online!; 2002:269117, Nov. 15, 2001, “Enamine Product Listing”, XP002240447, abstract.
Database Chemcats 'Online!; 2002:269451, Nov. 15, 2001, “Enamine Product Listing”, XP002240448, abstract.
Database Chemcats 'Online!; 2002:277993, Nov. 15, 2001, “Enamine Product Listing”, XP002240449, abstract.
Crane, R.K., and Mandelstam, P., “The Active Transport of Sugars by Various Preparations of Hamster Intestine,”Biochim. Biophys. Acta, 45: 460-476 (1960).
Feild, J.A., et al., “Cloning and Functional Characterization of a Sodium-Dependent Phosphate Transporter Expressed in Human Lung and Small Intestine,”Biochem. Biophys. Res. Commun., 258: 578-582 (1999).
Bastos Cecilia M.
Holmes-Farley Stephen Randall
Jozefiak Thomas H.
Papoulis Andrew T.
Genzyme Corporation
Hamilton Brook Smith & Reynolds P.C.
Wang Shengjun
LandOfFree
Phosphate transport inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphate transport inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphate transport inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3677702